Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 14,500 shares at $36.08 ($523K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
Open-market sale of $523k ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |